Navigation Links
Hy-Vee Unveils New Generic Drug Program

DES MOINES, Iowa, Jan. 11 /PRNewswire/ -- Hy-Vee officials announced today that a new generic prescription drug program will begin Tuesday Jan. 15 in all of their supermarkets and drugstores.

The program offers a 30-day supply of 400 generic drugs at a cost of $4 per prescription. The medicines on the list include antibiotics and drugs that treat aliments such as allergies, asthma, arthritis, diabetes, cholesterol and digestive issues.

There are no forms to fill out or special cards to carry and the program is available to all customers regardless of insurance or co-pays. Lists of the generic medicines included in the program will be available at every pharmacy counter and online at beginning Jan. 15.

"We embark on this program in the spirit of exceptional value and helpful service. Those are our trademarks," said Hy-Vee CEO Ric Jurgens. "But we also do it out of a deep commitment to helping customers live easier, healthier, happier lives."

Generic drugs help people save money, especially those without insurance or with high drug co-payments and seniors in the "doughnut hole" of their Medicare drug coverage. The program is expected to be well-received by employer groups as well.

Helping customers and benefit groups save money was but one incentive for the program. Just as important as the cost-savings of generic prescriptions are the education and patient counseling provided by Hy-Vee pharmacists when it comes to medication management and related wellness issues.

"The landscape of medicine in regard to drug therapy is changing," said Bob Egeland, assistant vice president of pharmacy. "Pharmacists are exceptionally trained to help customers understand generic drugs. But at Hy-Vee, it's not just about filling a prescription. We have an entire team of friendly, approachable health care professionals with the knowledge and expertise to assist customers in all of their health care needs."

For example, millions of Americans have chronic diseases such as diabetes and cardiovascular issues. Moving those patients to a generic prescription if they are not already on one is the first step, said Egeland. Just as important is helping the costumer understand what lifestyle changes can be made that may reduce the need for the medication.

"We pride ourselves on the trust we develop with our customers, a trust that assures everyone who steps up to a Hy-Vee counter that we will always be there to guide them on their health and wellness journey."

In the last several years, the company has focused on programs and events that promote healthy lifestyles. In addition to adding pharmacies to its stores, the company's HealthMarkets offer an array of private label, natural and organic products; registered dietitians at more than 100 locations help customers address all of their health and wellness needs; and classes and events held in Hy-Vee Club rooms cover a variety of topics such as disease management, diet, exercise and healthy cooking.

In 2007 the company sponsored the inaugural Hy-Vee Triathlon to get people excited about having fun while developing a fitness routine.

Hy-Vee, Inc. is an employee-owned corporation operating 222 retail stores in seven Midwestern states. For 2007 the company recorded total sales of $5.6 billion, ranking it among the top 20 supermarket chains and the top 40 private companies in the United States.

SOURCE Hy-Vee, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. RSNA 2007: Siemens Medical Solutions Unveils an Unprecedented Number of Leading-Edge Solutions to Help Customers Improve Patient Care and Reduce Costs
2. SPO Medical Unveils New Oximetry Devices for European Markets
3. The Menninger Clinic Unveils Plans for Mental Health Epicenter; Exceeds Halfway Point in $125 Million Capital Campaign
4. GigaLinx Unveils GEViewer(TM)- Industrys First Solution for Directly Connecting a GigE Camera to a Monitor
5. HGS unveils positive QOL results from Phase 2B trial of Albuferon for hepatits C
6. Dr. Dan L. Fortenbacher, O.D., FCOVD, Becomes 29th President of College of Optometrists in Vision Development (COVD); Unveils 7-Part Development Plan for Ongoing Growth
7. Neurotechnology Industry Organization Unveils Top 10 Neuroscience Trends of 2007
8. Steelcase Unveils the Walkstation to Bring Healthy Habits to The Workplace
10. Kiplinger Unveils Educational Video on Long-Term Care
11. Saks Fifth Avenue Unveils Five Magical Holiday Gifts
Post Your Comments:
(Date:11/27/2015)... ... November 27, 2015 , ... Avid collector, Andrew Hawley ... Michigan boxing style concert posters. This is one of Joplin's most famous and beautiful ... at the University of Michigan in Ann Arbor. The According to Hawley, "It is ...
(Date:11/26/2015)... ... November 26, 2015 , ... Patients at ... Michigan, have come together on Thanksgiving Day to share the things that they ... on the Serenity Point YouTube channel, patients displayed what they wrote on index ...
(Date:11/26/2015)... ... November 26, 2015 , ... ... eReferral system for diagnostic imaging in the Waterloo region. Using the Ocean Platform, ... Medicine tests directly from their electronic medical record (EMR) without the need for ...
(Date:11/26/2015)... ... November 26, 2015 , ... The Catalent ... and the need to integrate dose form selection in early phase drug development. ... membership organization supporting and bringing together the UK’s emerging life sciences companies, corporate ...
(Date:11/26/2015)... , ... November 26, 2015 , ... PRMA Plastic Surgery ... 19, 2015, our surgeons performed their 6,000th free flap breast reconstruction surgery! , “What ... up every day excited to rebuild lives and it’s an honor to have served ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... November 26, 2015 ... the "Radioimmunoassay Market by Type (Reagents ... Industry, Academics, Clinical Diagnostic Labs), Application (Research, ... to 2020" report to their offering. ... the addition of the "Radioimmunoassay Market ...
(Date:11/25/2015)... Nov. 25, 2015  Amgen (NASDAQ: AMGN ) ... (BLA) with the United States ... a biosimilar candidate to Humira ® (adalimumab). Amgen ... submitted to the FDA and represents Amgen,s first BLA ... E. Harper , M.D., executive vice president of Research ...
(Date:11/25/2015)... , Nov. 25, 2015 On Tuesday, ... federal bellwether trial against Wright Medical Technology, Inc. ... their Conserve metal-on-metal hip implant device, awarded $11 ... a two week trial and three days of ... hip device was defectively designed and unreasonably dangerous, ...
Breaking Medicine Technology: